Literature DB >> 26161699

Analysis of the UHRF1 expression in serum and tissue for gastric cancer detection.

Mengyuan Ge1, Zhen Gui, Xiaoming Wang, Feng Yan.   

Abstract

OBJECTIVE: To analyze the Ubiquitin-like with PHD and ring finger domains (UHRF) 1 expression in gastric cancer (GC).
METHODS: The concentrations of UHRF1 DNA in serum were compared between 187 GC patients and 56 healthy controls using real-time PCR. Immunohistochemical analysis using tissue microarrays was performed.
RESULTS: UHRF1 DNA levels were significantly higher in GC patients compared to healthy controls (p < 0.001) and have associations with age and lymph node metastasis (LNM). The UHRF1 expression was significantly higher in tumor tissue than matched normal tissues (p < 0.001).
CONCLUSIONS: The UHRF1 expression in serum and tissue may represent a novel biomarker for GC diagnosis and prognosis.

Entities:  

Keywords:  Serum; UHRF1; stomach cancer; tissue microarray; tumor marker

Mesh:

Substances:

Year:  2015        PMID: 26161699     DOI: 10.3109/1354750X.2015.1061599

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  5 in total

1.  The long non-coding RNA UPAT promotes gastric cancer cell progression via UHRF1.

Authors:  Chaoyong Liu; Minghua Ai; Yan Zhang; Jie Li; Chao Xu
Journal:  Genes Genomics       Date:  2022-03-16       Impact factor: 2.164

2.  Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy.

Authors:  Hani Choudhry; Mazin A Zamzami; Ziad Omran; Wei Wu; Marc Mousli; Christian Bronner; Mahmoud Alhosin
Journal:  Oncol Lett       Date:  2017-10-30       Impact factor: 2.967

3.  SHMT2 Drives the Progression of Colorectal Cancer by Regulating UHRF1 Expression.

Authors:  Ximao Cui; Yanfen Cui; Tao Du; Xiaohua Jiang; Chun Song; Shun Zhang; Chiye Ma; Yun Liu; Qing Ni; Yuzhe Gao; Guanghui Wang
Journal:  Can J Gastroenterol Hepatol       Date:  2022-02-15

Review 4.  Roles of E3 ubiquitin ligases in gastric cancer carcinogenesis and their effects on cisplatin resistance.

Authors:  Huizhen Wang; Yida Lu; Mingliang Wang; Youliang Wu; Xiaodong Wang; Yongxiang Li
Journal:  J Mol Med (Berl)       Date:  2021-01-03       Impact factor: 4.599

Review 5.  Targeting the SET and RING-associated (SRA) domain of ubiquitin-like, PHD and ring finger-containing 1 (UHRF1) for anti-cancer drug development.

Authors:  Debasis Patnaik; Pierre-Olivier Estève; Sriharsa Pradhan
Journal:  Oncotarget       Date:  2018-05-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.